Literature DB >> 29353435

Letter to the editor: local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.

Alexandre Roux1,2, Marc Zanello1,2, Johan Pallud3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29353435     DOI： 10.1007/s11060-018-2770-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  6 in total

1.  Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort.

Authors:  Johan Pallud; Etienne Audureau; Georges Noel; Robert Corns; Emmanuèle Lechapt-Zalcman; Julien Duntze; Vladislav Pavlov; Jacques Guyotat; Phong Dam Hieu; Pierre-Jean Le Reste; Thierry Faillot; Claude-Fabien Litre; Nicolas Desse; Antoine Petit; Evelyne Emery; Jimmy Voirin; Johann Peltier; François Caire; Jean-Rodolphe Vignes; Jean-Luc Barat; Olivier Langlois; Edouard Dezamis; Eduardo Parraga; Marc Zanello; Edmond Nader; Michel Lefranc; Luc Bauchet; Bertrand Devaux; Philippe Menei; Philippe Metellus
Journal:  Neuro Oncol       Date:  2015-07-16       Impact factor: 12.300

2.  Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice.

Authors:  Alexandre Roux; Sophie Peeters; Marc Zanello; Rabih Bou Nassif; Georges Abi Lahoud; Edouard Dezamis; Eduardo Parraga; Emmanuelle Lechapt-Zalcmann; Frédéric Dhermain; Sarah Dumont; Guillaume Louvel; Fabrice Chretien; Xavier Sauvageon; Bertrand Devaux; Catherine Oppenheim; Johan Pallud
Journal:  J Neurooncol       Date:  2017-07-01       Impact factor: 4.130

3.  A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.

Authors:  Manfred Westphal; Dana C Hilt; Enoch Bortey; Patrick Delavault; Robert Olivares; Peter C Warnke; Ian R Whittle; Juha Jääskeläinen; Zvi Ram
Journal:  Neuro Oncol       Date:  2003-04       Impact factor: 12.300

Review 4.  Carmustine wafer implantation for high-grade gliomas: Evidence-based safety efficacy and practical recommendations from the Neuro-oncology Club of the French Society of Neurosurgery.

Authors:  A Roux; F Caire; J Guyotat; P Menei; P Metellus; J Pallud
Journal:  Neurochirurgie       Date:  2017-11-06       Impact factor: 1.553

5.  Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up.

Authors:  Alessandro Della Puppa; Giuseppe Lombardi; Marta Rossetto; Oriela Rustemi; Franco Berti; Diego Cecchin; Marina Paola Gardiman; Giuseppe Rolma; Luca Persano; Vittorina Zagonel; Renato Scienza
Journal:  J Neurooncol       Date:  2016-10-18       Impact factor: 4.130

6.  Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.

Authors:  William Sage; Mathew Guilfoyle; Catriona Luney; Adam Young; Rohitashwa Sinha; Donatella Sgubin; Joseph H McAbee; Ruichong Ma; Sarah Jefferies; Rajesh Jena; Fiona Harris; Kieren Allinson; Tomasz Matys; Wendi Qian; Thomas Santarius; Stephen Price; Colin Watts
Journal:  J Neurooncol       Date:  2017-11-14       Impact factor: 4.130
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.